A new report from market intelligence firm IQVIA has found the overall demand for prescription medicines "remains suppressed" as a result of the COVID-19 pandemic while oncologists report a widespread reduction in the rate of new diagnosis and treatment. …
IQVIA: Demand still 'suppressed" and 'concerns' over cancer outcomes
September 1, 2020 Latest NewsNews of the Day
Latest Video
New Stories
-
Patients and clinicians defend MS treatment choice during review stakeholder meeting
November 5, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News -
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News